Publications by authors named "Ivan Marcipar"

Claim this Profile
N
Nasal vaccination against : a dual approach for prevention and treatment of chronic Chagas cardiomyopathy.
Paula Cacik, Maria Florencia Pacini, Camila Bulfoni Balbi, Brenda Dinatale, Genaro Diaz, Iván Sergio Marcipar

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in rams.
María Celeste Moran, Agostina Tammone Santos, Paula Dominguez, Lucila Moriones, María Victoria Nieto Farias, Iván Santiago Marcipar

Vet Immunol Immunopathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of Sustained Immunity Following Vaccination with Live Attenuated Parasites Combined with Saponin-Based Adjuvants.
Brenda A Zabala, María Elisa Vázquez, Daniela E Barraza, Andrea C Mesías, Federico Ramos, Iván S Marcipar

Biology (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Cellular Immune Biomarkers with Machine Learning to Identify Potential Correlates of Protection for a Vaccine.
Juan Cruz Gamba, Eliana Borgna, Estefanía Prochetto, Ana Rosa Pérez, Alexander Batista-Duharte, Iván Marcipar

Vaccines (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel IgM-based lateral flow assay for diagnosis of congenital Chagas disease.
Luz M Peverengo, Leandro E Peretti, Maria B Warszatska, Guillermo Moscatelli, Samanta Moroni, Iván S Marcipar

Infect Dis (Lond)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual dimorphism-driven differences are overcome in a preclinical vaccine model against .
Camila Bulfoni Balbi, Maria Florencia Pacini, Brenda Dinatale, Cecilia Farré, Paula Cacik, Iván Marcipar

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of myeloid-derived suppressor cell dynamics potentiates vaccine protection in multiple mouse models of infection.
Eliana Borgna, Estefanía Prochetto, Juan Cruz Gamba, Elba Mónica Vermeulen, Carolina Verónica Poncini, Iván Marcipar

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal Trans-Sialidase Vaccine Mitigates Acute and Chronic Pathology in a Preclinical Oral Chagas Disease Model.
Maria Florencia Pacini, Camila Bulfoni Balbi, Brenda Dinatale, Cecilia Farré, Paula Cacik, Iván Marcipar

Vaccines (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved serodiagnosis of Trypanosoma vivax infections in cattle reveals high infection rates in the livestock regions of Argentina.
Iván Alejandro Bontempi, Diego Gustavo Arias, Graciela Verónica Castro, Luz María Peverengo, Genaro Francisco Díaz, Iván Marcipar

PLoS Negl Trop Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple protocol for measuring CD11b+ GR-1+ (Ly6C+/Ly6G+) myeloid cells from a minimum volume of mouse peripheral blood.
Eliana Borgna, Juan Cruz Gamba, Estefanía Prochetto, Iván Marcipar, Gabriel Cabrera

Methods Cell Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The high identity of the Trypanosoma cruzi Group-I of trans-sialidases points them as promising vaccine immunogens.
Maria Florencia Pacini, Adrián Perdomini, Camila Bulfoni Balbi, Brenda Dinatale, Fernando E Herrera, Iván Marcipar

Proteins· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coupling ELISA to smartphones for POCT of chronic and congenital Chagas disease.
Federico Schaumburg, Nazarena Pujato, Luz María Peverengo, Iván Sergio Marcipar, Claudio Luis Alberto Berli

Talanta· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity.
María F Pacini, Camila Bulfoni Balbi, Brenda Dinatale, Florencia B González, Estefania Prochetto, Iván Marcipar

Acta Trop· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas.
Alejandro D Ricci, Leonel Bracco, Emir Salas-Sarduy, Janine M Ramsey, Melissa S Nolan, Iván S Marcipar

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of myeloid-derived suppressor cells during Trypanosoma cruzi infection.
Eliana Borgna, Estefanía Prochetto, Juan Cruz Gamba, Iván Marcipar, Gabriel Cabrera

Int Rev Cell Mol Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of low-cost cage-like particles to formulate veterinary vaccines.
Giuliana A Lupi, Florencia X Santiago Valtierra, Gabriel Cabrera, Roque Spinelli, Álvaro S Siano, Iván Marcipar

Vet Immunol Immunopathol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA) administered by parenteral or mucosal routes against Brucella ovis in BALB/c mice.
María Celeste Moran, María Paula Dominguez, Angel Ricardo Bence, Marcelo Gastón Rodriguez, Fernando Alberto Goldbaum, Ivan Sergio Marcipar

Res Vet Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Film Forming Nanogels for Needle-Free Transdermal Vaccination.
Ana Sonzogni, Gabriel Cabrera, Giuliana Lupi, Luis Gugliotta, Verónica Gonzalez, Iván Marcipar

Macromol Biosci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection.
Estefanía Prochetto, Iván Bontempi, Luz Rodeles, Gabriel Cabrera, Miguel Vicco, Iván Marcipar

Acta Trop· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection.
Maria Florencia Pacini, Florencia Belén González, Brenda Dinatale, Camila Bulfoni Balbi, Silvina Raquel Villar, Iván Marcipar

Vaccine· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased epicardial adipose tissue thickness associated with increased metabolic risk and the presence of heart failure in patients with Chronic Chagas disease.
Luz María Rodeles, Maximiliano Castro, María Ayelen Gaitán Zamora, Roberto Savarino, Luz María Peverengo, Iván Marcipar

Trans R Soc Trop Med Hyg· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against .
Juan Cruz Gamba, Carolina Roldán, Estefanía Prochetto, Giuliana Lupi, Iván Bontempi, Iván Marcipar

Front Cell Infect Microbiol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of anti-B13 antibodies over time in a cohort of chronic infected by Trypanosoma cruzi. Its relationship with specific treatment and clinical status.
Verónica Olivera, Maria L Bizai, Evelyn Arias, Santiago Suasnabar, Oscar Bottasso, Ivan Marcipar

Acta Trop· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Autoreactive Anti-β2 Adrenergic Antibodies May Contribute to Insulin Resistance Profile in Patients with Chronic Chagas Disease.
Luz María Rodeles, Miguel Hernán Vicco, Álvaro Siano, Leonardo Andrés Fuchs, Luz María Peverengo, Iván Sergio Marcipar

Pathogens· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital chagas disease: Development and assessment of a specific IgM capture-based assay for diagnosis of transmission.
Luz María Peverengo, Luz María Rodeles, Camila Maldonado, Griselda Ballering, Nazarena Pujato, Iván Marcipar

Acta Trop· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis